Back to search

Article

Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients

2023-08-24

Abstract excerpt

<title>Abstract</title> <p>Fanconi anemia (FA) is a rare hereditary disease characterized by an inactivating mutation in the FA/BRCA pathway, critical for the effective repair of DNA interstrand crosslinks (ICLs). The disease is characterized by progressing bone marrow failure, congenital abnormalities and an increased risk to develop malignancies early in life, in particular head and neck squamous cell carcinoma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3346bc72-d927-57ba-b230-d6918d7a5ce3
DOI
10.21203/rs.3.rs-3251364/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patientsDOI 10.21203/rs.3.rs-3251364/v1
Select a neighboring publication to make it the new centre.